Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status by Mercedes Porosnicu, Mercedes Porosnicu, Anderson O’Brien Cox, Joshua D. Waltonen, Paul M. Bunch, Ralph D’Agostino, Ralph D’Agostino, Thomas W. Lycan, Thomas W. Lycan, Richard Taylor, Dan W. Williams, Xiaofei Chen, Kirtikar Shukla, Brian E. Kouri, Tiffany Walker, Tiffany Walker, Gregory Kucera, Gregory Kucera, Hafiz S. Patwa, Hafiz S. Patwa, Christopher A. Sullivan, Christopher A. Sullivan, J. Dale Browne, J. Dale Browne, Cristina M. Furdui, Cristina M. Furdui

Get full text